Lifecore Biomedical (LFCR) has completed its turnaround, emerging as a pure-play US-based CDMO with a cleaned-up balance ...

Eli Lilly hiked its revenue growth guidance by 7%, while Novo Nordisk was forced to slash its targets by ~12%. See why I'm ...

Learn more about whether Charles River Laboratories International, Inc. or West Pharmaceutical Services, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' ...

The aluminum caps and closures market segment is undergoing a continuous growth due to the increase of packaged beverage growth, growing pharmaceutical manufacturing, and the global movement towards ...

Choosing a luxury location on the island comes down to seasonality. If you’re travelling during the summer (July and August ...

While the shift from rigid to flexible packaging formats requires strategic investments in equipment and processes, the right ...

Vial's INHBE siRNA is a first-in-class, liver-targeted (GalNAc-conjugated) siRNA therapy that silences INHBE and its gene product, Activin E -- Leading key opinion leaders (KOL ...

Industry Analysis Examines How Cost, Safety, and Access Considerations Shape Semaglutide Choices as MEDVi Lists Compounded ...

BRIDGEWATER, N.J., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (Nasdaq: AMRX) today announced that the U.S. Food and Drug Administration (FDA) has ...